BASF and Takeda Chemical Industries
This article was originally published in The Tan Sheet
Executive Summary
German and Japanese firms announce July 28 they will combine their bulk vitamins businesses. Following regulatory approvals, the combined operation will have an estimated 30% share of the worldwide vitamins market, the companies report. BASF sales to the pharmaceutical, food and animal nutrition industries totaled roughly $500 mil. in 1999; Takeda's global sales to the same industries were approximately $240 mil. The proposed merger closely follows a landmark vitamin price-fixing case in which both BASF and Takeda pleaded guilty (1"The Tan Sheet" Sept. 13, 1999, p. 4)
You may also be interested in...
Takeda, Eisai, Daiichi Plead Guilty In Criminal "Vitamin Cartel" Case
Three Japanese vitamin manufacturers have agreed to plead guilty to charges associated with "a worldwide conspiracy to raise and fix prices and allocate market shares for certain vitamins sold in the U.S. and elsewhere," the Department of Justice announced Sept. 9.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands